There were two different stories for InMode (NASDAQ: INMD) in 2022. In the first half of the year, the medical device stock plunged 68%. However, in the second half, InMode roared back, with its ...

Individual investors who want help picking stocks have more than a few options to choose from, including the recommendations of Wall Street analysts. Analysts usually have considerably more resources ...

InMode shares rose sharply in anticipation of the company's second-quarter earnings report. Soaring sales of medical devices used for minimally invasive cosmetic procedures drove profits 25% higher ...

InMode (NASDAQ:INMD) is gearing up to announce its quarterly earnings on Tuesday, 2026-02-10. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...

These projections put the company in a fairly good position and indicate that on the low side InMode is near fair value, but on the high side has a lot of potential. Showing these various cases, ...

InMode's valuations have been discounted drastically compared to its 3Y means and its peers, suggesting its overly depressed price target of $48.30. However, we believe an upward revision to P/E of ...

The market for cosmetic surgery-related procedures is worth over $63 billion annually and is growing fast. InMode is gaining a share of the aesthetics market, with proprietary devices and workstations ...

InMode Ltd. (NASDAQ: INMD) Securities Fraud Class Action: The complaint alleges that InMode repeatedly touted the demand for its devices and told investors that the devices were never sold at a ...